Clinical Trials Logo

PTA clinical trials

View clinical trials related to PTA.

Filter by:
  • None
  • Page 1

NCT ID: NCT03426293 Recruiting - Surgery Clinical Trials

Measuring the ACT During Non-cardiac Arterial Procedures.

MANCO
Start date: December 21, 2016
Phase:
Study type: Observational [Patient Registry]

Aim of the MANCO study is to establish for once and for all that monitoring the effect of heparin during NCVI (Non-Cardiac Vascular Interventions) is essential to ensure the individual patient of safe and tailor-made anticoagulation. Not measuring the effect of the administered heparin exposes the patient to unnecessary risks of thrombo-embolic and bleeding complications. First aim of the MANCO study is to prove that the standardized bolus of 5000 IU of heparin, used by 90% of vascular specialists in Europe, results in inadequate anticoagulation in more than 80% of patients. These measurements will be performed using the Hemostasis Management System by Medtronic.